MEETINGS - Genetic testing and alzheimer disease (US) October 1997:
This article was originally published in Clinica
The Stanford University Program in Genomics, Ethics and Society will host a conference on Genetic Testing and Alzheimer Disease in California on October 25. Ethical questions about the potential uses of tests to detect genetic predisposition for Alzheimer's will be addressed and debated at the conference. Contact Laura McConnell for more details. Tel: +1 650 498 6934.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.